Your session is about to expire
← Back to Search
Pectointercostal fascia blocks for Postoperative Pain (SPIFFY Trial)
Phase 4
Waitlist Available
Led By Wing Lam
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 6 hours for 24 hours post-operatively
Awards & highlights
SPIFFY Trial Summary
This trial is looking to see if a regional block helps with pain relief for those who have undergone heart surgery.
Eligible Conditions
- Postoperative Pain
SPIFFY Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ every 6 hours for 24 hours post-operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 6 hours for 24 hours post-operatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opioid consumption
Secondary outcome measures
ICU length of stay
Local anesthetic systemic toxicity effects
Opioid consumption in 24 hours
+3 moreSPIFFY Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
This group of patients will undergo placement of US guided pectointercostal fascia blocks.
Group II: PlaceboPlacebo Group1 Intervention
The control group patients will receive the same intraoperative analgesia management. A PIF block will not be performed, instead, a peripheral nerve block catheter will be secured to the skin surface and connected to a CADD™ pump. As the catheter is taped to the skin surface the control group patients will not be exposed to the risks of peripheral nerve block placement.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,019 Total Patients Enrolled
Wing LamPrincipal InvestigatorUniversity of Alberta
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new patients able to partake in this research endeavor?
"According to the information on clinicaltrials.gov, participant recruitment for this medical trial has terminated as of August 2nd 2022. The study was originally posted October 1st 2022 and is no longer searching for patients at present; however, there are 484 other trials actively recruiting participants."
Answered by AI
How secure is Pectointercostal fascia blocks for those undergoing the procedure?
"Pectointercostal fascia blocks have been approved for therapeutic use, thus earning a safety rating of 3 on our assessment scale."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger